John A. Lewicki
2014
In 2014, John A. Lewicki earned a total compensation of $1.8M as Executive Vice President, Research and Development at OncoMed Pharmaceuticals, a 144% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,010 |
|---|---|
| Option Awards | $646,270 |
| Salary | $377,171 |
| Stock Awards | $620,600 |
| Total | $1,776,051 |
Lewicki received $646.3K in option awards, accounting for 36% of the total pay in 2014.
Lewicki also received $132K in non-equity incentive plan, $377.2K in salary and $620.6K in stock awards.
Rankings
In 2014, John A. Lewicki's compensation ranked 5,010th out of 13,032 executives tracked by ExecPay. In other words, Lewicki earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,010 out of 13,032 | 62nd |
Division Manufacturing | 1,786 out of 4,966 | 64th |
Major group Chemicals And Allied Products | 590 out of 1,686 | 65th |
Industry group Drugs | 450 out of 1,365 | 67th |
Industry Pharmaceutical Preparations | 359 out of 1,043 | 66th |
Source: SEC filing on April 29, 2016.
Lewicki's colleagues
We found two more compensation records of executives who worked with John A. Lewicki at OncoMed Pharmaceuticals in 2014.